CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.53 USD | +1.50% |
|
+0.63% | -1.26% |
| May. 07 | Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024 | CI |
| May. 07 | Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116 | MT |
ETFs positioned on Cardinal Health, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | +0.32% | - | |
| 0.01% | 2 M€ | +3.16% | - | |
| 0.01% | 0 M€ | +0.34% | - | |
| 0.01% | 0 M€ | +0.50% | - | |
| 0.01% | 0 M€ | +3.95% | - | |
| 1.81% | 0 M€ | +6.50% | - |
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
99.53
USD
Average target price
112.4
USD
Spread / Average Target
+12.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.26% | 24.24B | |
| +20.94% | 72.78B | |
| +5.13% | 8.59B | |
| +8.25% | 8.38B | |
| -19.42% | 8.09B | |
| +5.56% | 4.81B | |
| +16.83% | 4.32B | |
| -1.83% | 4.05B | |
| -1.65% | 3.93B | |
| +26.97% | 3.79B |
- Stock Market
- Equities
- CAH Stock
- Funds and ETFs Cardinal Health, Inc.